ZA986475B - Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it. - Google Patents

Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.

Info

Publication number
ZA986475B
ZA986475B ZA9806475A ZA986475A ZA986475B ZA 986475 B ZA986475 B ZA 986475B ZA 9806475 A ZA9806475 A ZA 9806475A ZA 986475 A ZA986475 A ZA 986475A ZA 986475 B ZA986475 B ZA 986475B
Authority
ZA
South Africa
Prior art keywords
carbazoly
propanole
loxy
methoxyphenoxy
ethylamino
Prior art date
Application number
ZA9806475A
Other languages
English (en)
Inventor
Erhard Reinholz
Peter Beyer
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of ZA986475B publication Critical patent/ZA986475B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA9806475A 1997-07-22 1998-07-21 Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it. ZA986475B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97112491A EP0893440A1 (en) 1997-07-22 1997-07-22 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
ZA986475B true ZA986475B (en) 2000-01-21

Family

ID=8227094

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9806475A ZA986475B (en) 1997-07-22 1998-07-21 Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.

Country Status (31)

Country Link
EP (2) EP0893440A1 (cs)
JP (1) JP2001510824A (cs)
KR (1) KR100336229B1 (cs)
CN (1) CN1125047C (cs)
AR (1) AR015133A1 (cs)
AT (1) ATE236123T1 (cs)
AU (1) AU740453B2 (cs)
BR (1) BR9810776A (cs)
CA (1) CA2296637C (cs)
CZ (1) CZ296947B6 (cs)
DE (1) DE69812964T2 (cs)
DK (1) DK1000027T3 (cs)
ES (1) ES2195366T3 (cs)
HR (1) HRP980406A2 (cs)
HU (1) HUP0003198A3 (cs)
IL (1) IL133677A (cs)
MA (1) MA26523A1 (cs)
MY (1) MY117734A (cs)
NO (1) NO313588B1 (cs)
NZ (1) NZ502136A (cs)
PE (1) PE96999A1 (cs)
PL (1) PL191602B1 (cs)
PT (1) PT1000027E (cs)
RU (1) RU2202542C2 (cs)
SI (1) SI1000027T1 (cs)
TR (1) TR200000148T2 (cs)
TW (1) TW505631B (cs)
UY (1) UY25108A1 (cs)
WO (1) WO1999005105A1 (cs)
YU (1) YU2200A (cs)
ZA (1) ZA986475B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2227206T3 (es) * 2000-04-03 2005-04-01 F. Hoffmann-La Roche Ag Soluciones concentradas de carvedilol.
EP1655285A1 (en) * 2000-06-28 2006-05-10 Teva Pharmaceutical Industries Ltd. Method for preparation of a crystalline form of carvedilol (form II)
US6699997B2 (en) 2000-06-28 2004-03-02 Teva Pharmaceutical Industries Ltd. Carvedilol
DE60212130D1 (en) * 2001-07-13 2006-07-20 Smithkline Beecham Corp Carvedilolpolymorph
EP1429734B1 (en) 2001-09-21 2007-12-26 Egalet A/S Controlled release solid dispersions of carvedilol
ES2291503T3 (es) * 2001-09-28 2008-03-01 F. Hoffmann-La Roche Ag Formas pseudopolimorficas de carvedilol.
PL371409A1 (en) * 2002-01-15 2005-06-13 Teva Pharmaceutical Industries Ltd. Crystalline solids of carvedilol and processes for their preparation
WO2003092622A2 (en) * 2002-04-30 2003-11-13 Sb Pharmco Puerto Rico Inc. Carvedilol monocitrate monohydrate
CA2492084A1 (en) * 2002-06-27 2004-01-08 Sb Pharmco Puerto Rico Inc. Carvedilol hydobromide
AU2003248746B2 (en) * 2002-06-27 2009-01-08 Smithkline Beecham (Cork) Limited Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
WO2004041252A1 (en) * 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
WO2004094378A1 (en) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
US7750036B2 (en) 2003-11-25 2010-07-06 Sb Pharmco Puerto Rico Inc. Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
PL1838670T3 (pl) * 2004-12-09 2010-03-31 Zach System Spa Sposób wytwarzania karwedilolu i jego enancjomerów
WO2006135757A1 (en) * 2005-06-09 2006-12-21 Teva Pharmaceutical Industries Ltd. Crystalline forms of carvedilol and processes for their preparation
EP1991527A2 (en) 2006-06-28 2008-11-19 Teva Pharmaceutical Industries Ltd Polymorphous forms of carvedilol phosphate
RU2366653C2 (ru) * 2006-07-03 2009-09-10 Ооо "Нанокриохимия" Способ получения рентгеноаморфной модификации карведилола
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
EP2445487A2 (en) 2009-06-24 2012-05-02 Egalet Ltd. Controlled release formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
CA2296637A1 (en) 1999-02-04
HUP0003198A3 (en) 2002-10-28
HUP0003198A2 (en) 2001-03-28
CN1125047C (zh) 2003-10-22
JP2001510824A (ja) 2001-08-07
SI1000027T1 (en) 2003-10-31
EP0893440A1 (en) 1999-01-27
DE69812964T2 (de) 2004-03-04
MY117734A (en) 2004-07-31
IL133677A (en) 2004-06-01
PL191602B1 (pl) 2006-06-30
NO20000301L (no) 2000-01-21
PE96999A1 (es) 1999-10-12
CN1264366A (zh) 2000-08-23
DE69812964D1 (de) 2003-05-08
KR100336229B1 (ko) 2002-05-09
AR015133A1 (es) 2001-04-18
NO313588B1 (no) 2002-10-28
MA26523A1 (fr) 2004-12-20
CZ2000221A3 (cs) 2000-05-17
HRP980406A2 (en) 1999-04-30
IL133677A0 (en) 2001-04-30
RU2202542C2 (ru) 2003-04-20
TW505631B (en) 2002-10-11
EP1000027A1 (en) 2000-05-17
NZ502136A (en) 2002-05-31
KR20010022097A (ko) 2001-03-15
AU8631998A (en) 1999-02-16
WO1999005105A1 (en) 1999-02-04
CA2296637C (en) 2005-11-15
CZ296947B6 (cs) 2006-08-16
TR200000148T2 (tr) 2000-07-21
ATE236123T1 (de) 2003-04-15
DK1000027T3 (da) 2003-07-21
PT1000027E (pt) 2003-07-31
AU740453B2 (en) 2001-11-01
PL338432A1 (en) 2000-11-06
YU2200A (sh) 2002-03-18
NO20000301D0 (no) 2000-01-21
EP1000027B1 (en) 2003-04-02
HK1029339A1 (en) 2001-03-30
ES2195366T3 (es) 2003-12-01
BR9810776A (pt) 2000-09-19
UY25108A1 (es) 2000-12-29

Similar Documents

Publication Publication Date Title
ZA986475B (en) Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.
ZA985364B (en) Pharmaceutical formulations containing voriconazole.
AU1157599A (en) Pyrimidinone compounds and pharmaceutical compositions containing them
ZA988585B (en) Pharmaceutical compositions containing plasma protein.
HUP0001539A3 (en) 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
HUP0001541A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP0102372A2 (hu) Dihidropirimidin-származékok, ezek előállítása és ezeket tartalmazó gyógyszerkészítmények
ZA9710015B (en) Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications.
AU6120498A (en) 4,4-difluoro-2,3,4,5-tetrahydro-1h-1-benzazepine derivatives and drug compositions containing them
HUP9601328A3 (en) 4-(aryl-amino-methylene)-2,4-dihydro-pyrazol-3-one derivatives and pharmaceutical compositions containing them
HUP9902138A3 (en) N-[4-(heteroarylmethyl)phenyl]-heteroarylamine derivatives, their preparation and pharmaceutical compositions containing them
ZA9710593B (en) Antisebum and antioxidant compositions containing gugulipid and fractions thereof.
IL136937A0 (en) τ-GLUTAMYL AND β-ASPARTYL CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL138725A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
HUP0002853A3 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
ZA991590B (en) Indole derivatives and pharmaceutical compositions comprising the same.
ZA989680B (en) Pharmaceutical composition.
NO20012727L (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
IL135723A (en) 1'-Ä4-Ä1-4-Fluorophenyl)-1H-indole-3-ylÜ-1-butylÜ-spiroÄisobenzofuran-1-(3H),4'-piperidineÜhydrohal ogenides and pharmaceutical compositions containing them
IL136612A (en) Phenylaminoalkyl-carboxylic acid derivatives and pharmaceutical compositions containing the same
EP0983243A4 (en) NOVEL QUINOLINE- AND NAPHTHALENECARBOXAMIDES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INHIBITING CALPAIN
ZA997511B (en) Novel heteroethynlene compounds and pharmaceutical and cosmetic compositions containing same.